Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace

将公共卫生电子支持 (ESP) 从实验室转变为市场

基本信息

  • 批准号:
    8919742
  • 负责人:
  • 金额:
    $ 33.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Accurate and complete disease surveillance is critical to enable public health authorities to detect and respond to disease outbreaks, epidemics, and even bioterrorism events. While legally required of healthcare practitioners and practices, most notifiable disease reporting is still done manually or through limited automated laboratory test result reporting. This creates a substantial burden on practitioners and produces sparse data that does not meet the full requirements of the agencies responsible for protecting public health. To address limitations in reporting and surveillance, the Centers for Disease Control and Prevention, beginning in 2005, sponsored a project to develop and pilot an open-source electronic system (called EHR Support for Public Health, or ESP) to automate the detection and reporting of notifiable diseases by taking advantage of the rich information coded into electronic health record (EHR) systems. Collaborating institutions included Harvard Medical School, Harvard Vanguard Medical Associates, and the Massachusetts Department of Public Health. CDC and AHRQ subsequently funded the creation of additional prototypes for syndromic surveillance, chronic disease prevalence monitoring, and automated detection and reporting of vaccine adverse events, as well as the fielding of ESP as a vehicle for enhanced surveillance of sexually transmitted diseases. We believe that ESP is a near-perfect basis for the NIH's Lab to Marketplace (Tools for Biomedical and Behavioral Research) SBIR solicitation. It represents advanced, proven-to-be-useful technology that was developed with substantial DHHS investment, but it is only in use so far at a handful of institutions. There is a real danger that ESP will never attain "lift-off" as a sustained, viable commercial activity. The overall goalsof this project are to realize the full functional potential of ESP, to make it more robust and easier to use and deploy, and to take the necessary steps to move it onto a pathway to wider deployment. Specifically, the project will take advantage of emerging healthcare data standards to increase portability of ESP across EHR systems and to reduce the maintenance and management burden on healthcare practices for the setup and use of ESP and for access to the data captured by the system. As an enabling component for enhancing disease detection, the project also includes the development of an automated processing module for free-text laboratory microbiology reports. Utilizing this foundation, the project will significantly extend te set of diseases detected within ESP and complete the existing prototype ESP capabilities mentioned above. The project involves close collaboration with experts at the organization (the Harvard Department of Population Medicine) that led the original development work on ESP as well as with the MetroHealth System of Northeast Ohio, a regional healthcare provider that has been running ESP on a production basis since 2009.
描述(由申请人提供):准确和完整的疾病监测是至关重要的,使公共卫生当局能够发现和应对疾病爆发,流行病,甚至生物恐怖主义事件。虽然法律要求医疗从业人员和做法,大多数应报告的疾病报告仍然是手动或通过有限的自动实验室检测结果报告。这给从业人员造成了沉重的负担,并产生了不符合负责保护公众健康的机构的全部要求的稀疏数据。为了解决报告和监测方面的局限性,疾病控制和预防中心从2005年开始赞助了一个项目,开发和试点一个开源电子系统(称为EHR支持公共卫生,或ESP),通过利用编码到电子健康记录(EHR)系统中的丰富信息,自动检测和报告应报告的疾病。合作机构包括哈佛医学院、哈佛先锋医疗协会和马萨诸塞州公共卫生部。CDC和AHRQ随后资助创建了更多原型,用于综合征监测、慢性病患病率监测、疫苗不良事件的自动检测和报告,以及使用ESP作为加强性传播疾病监测的工具。我们相信,ESP是NIH的实验室到市场(生物医学和行为研究工具)SBIR征集的一个近乎完美的基础。它代表了由DHHS大量投资开发的先进的、被证明是有用的技术,但到目前为止,它只在少数几个机构使用。有一个真实的危险,即ESP将永远不会实现“起飞”作为一个持续的,可行的商业活动。该项目的总体目标是实现ESP的全部功能潜力,使其更加健壮和简单 使用和部署,并采取必要措施将其推向更广泛的部署。具体而言,该项目将利用新兴的医疗保健数据标准,提高ESP在EHR系统中的可移植性,并减少医疗保健实践中ESP设置和使用以及访问系统捕获的数据的维护和管理负担。作为加强疾病检测的一个有利组成部分,该项目还包括开发一个用于自由文本实验室微生物学报告的自动处理模块。利用这一基础,该项目将大大扩展ESP中检测到的疾病,并完成上述现有的ESP原型功能。该项目涉及与组织(哈佛人口医学系)的专家密切合作,该组织领导了ESP的原始开发工作,以及与俄亥俄州东北部的MetroHealth System密切合作,该MetroHealth System是一家自2009年以来一直在生产基础上运行ESP的区域医疗保健提供商。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID M FRAM其他文献

DAVID M FRAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID M FRAM', 18)}}的其他基金

Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace
将公共卫生电子支持 (ESP) 从实验室转变为市场
  • 批准号:
    8781524
  • 财政年份:
    2014
  • 资助金额:
    $ 33.38万
  • 项目类别:
Safety Data Mining Based on Chemical Structures
基于化学结构的安全数据挖掘
  • 批准号:
    6865093
  • 财政年份:
    2005
  • 资助金额:
    $ 33.38万
  • 项目类别:
Discriminating Drug Safety Profiles in Polytherapy
综合治疗中药物安全性的区别
  • 批准号:
    6738316
  • 财政年份:
    2004
  • 资助金额:
    $ 33.38万
  • 项目类别:
Next-Generation Safety Data Mining System
下一代安全数据挖掘系统
  • 批准号:
    6549272
  • 财政年份:
    2002
  • 资助金额:
    $ 33.38万
  • 项目类别:
Next-Generation Safety Data Mining System
下一代安全数据挖掘系统
  • 批准号:
    6712111
  • 财政年份:
    2002
  • 资助金额:
    $ 33.38万
  • 项目类别:
Next-Generation Safety Data Mining System
下一代安全数据挖掘系统
  • 批准号:
    6684442
  • 财政年份:
    2002
  • 资助金额:
    $ 33.38万
  • 项目类别:
META-ANALYSIS OF DRUG ABUSE TREATMENT OUTCOME STUDIES
药物滥用治疗结果研究的荟萃分析
  • 批准号:
    3635541
  • 财政年份:
    1995
  • 资助金额:
    $ 33.38万
  • 项目类别:
META-ANALYSIS OF DRUG ABUSE TREATMENT OUTCOME STUDIES
药物滥用治疗结果研究的荟萃分析
  • 批准号:
    3635542
  • 财政年份:
    1995
  • 资助金额:
    $ 33.38万
  • 项目类别:
GENOMIC SEQUENCE SEARCH SOFTWARE FOR PROPHET II
Prophet II 的基因组序列搜索软件
  • 批准号:
    2326186
  • 财政年份:
    1994
  • 资助金额:
    $ 33.38万
  • 项目类别:
SEQUENCE DATA VISUALIZATION SOFTWARE FOR PROPHET
Prophet 的序列数据可视化软件
  • 批准号:
    2326134
  • 财政年份:
    1993
  • 资助金额:
    $ 33.38万
  • 项目类别:

相似海外基金

Biomarkers of spontaneous acute hepatitis C virus resolution
自发性急性丙型肝炎病毒消退的生物标志物
  • 批准号:
    8262303
  • 财政年份:
    2012
  • 资助金额:
    $ 33.38万
  • 项目类别:
Biomarkers of spontaneous acute hepatitis C virus resolution
自发性急性丙型肝炎病毒消退的生物标志物
  • 批准号:
    8458955
  • 财政年份:
    2012
  • 资助金额:
    $ 33.38万
  • 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
  • 批准号:
    8625266
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
Mechanisms of repeated control of acute hepatitis C infection in humans
反复控制人类急性丙型肝炎感染的机制
  • 批准号:
    9900734
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
  • 批准号:
    8445240
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
  • 批准号:
    8240544
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
  • 批准号:
    8054921
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
Mechanisms of repeated control of acute hepatitis C infection in humans
反复控制人类急性丙型肝炎感染的机制
  • 批准号:
    9246424
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
  • 批准号:
    7912185
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
Mechanisms of repeated control of acute hepatitis C infection in humans
反复控制人类急性丙型肝炎感染的机制
  • 批准号:
    9098149
  • 财政年份:
    2010
  • 资助金额:
    $ 33.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了